Newark, Del.
Delaware Biotechnology Institute, a collaboration between the state of Delaware, the University of Delaware, Delaware State University, and private businesses, has a $14 million research facility under construction at Newark's Delaware Technology Park. Construction is expected to be complete in November 2000 at the 70,000-sf facility where up to 50 researchers will be accommodated. Hercules Inc., a Wilmington, Del., specialty chemical firm, pledged $1 million to the project. Two other Delaware companies--AstraZeneca and DuPont--also plan to be involved in the project.
